Eli Lilly & Co. (LLY): Price and Financial Metrics

Eli Lilly & Co. (LLY): $750.77

4.03 (+0.54%)

POWR Rating

Component Grades

Momentum

C

Stability

C

Sentiment

Quality

C

LLY Price/Volume Stats

Current price $750.77 52-week high $800.78
Prev. close $746.74 52-week low $367.35
Day low $744.88 Volume 3,067,424
Day high $771.83 Avg. volume 3,085,720
50-day MA $761.42 Dividend yield 0.69%
200-day MA $612.79 Market Cap 713.35B

LLY Stock Price Chart Interactive Chart >


Eli Lilly & Co. (LLY) Company Bio


Eli Lilly and Company is an American pharmaceutical company headquartered in Indianapolis, Indiana, with offices in 18 countries. Its products are sold in approximately 125 countries. The company was founded in 1876 by, and named after, Col. Eli Lilly, a pharmaceutical chemist and veteran of the American Civil War. (Source:Wikipedia)


LLY Latest News Stream


Event/Time News Detail
Loading, please wait...

LLY Latest Social Stream


Loading social stream, please wait...

View Full LLY Social Stream

Latest LLY News From Around the Web

Below are the latest news stories about ELI LILLY & CO that investors may wish to consider to help them evaluate LLY as an investment opportunity.

2024’s Power Players: 7 Stocks Racing to a Trillion Valuation

Whether in 2024, or in the years ahead, each of these seven stocks could become the next trillion dollar companies.

Thomas Niel on InvestorPlace | January 1, 2024

3 Ken Griffin Stocks to Invest Like Citadel

Invest like Citadel founder and billionaire Ken Griffin with these stocks that have strong potential heading into 2024.

Alex Sirois on InvestorPlace | December 30, 2023

Top 3 Large-Cap Growth Stock Picks for the New Year

Crisis is creating opportunity for investors with some of these large-cap growth stocks for New Year 2024.

Ian Cooper on InvestorPlace | December 29, 2023

Why Fusion Pharmaceuticals (FUSN) Stock Was Up 14% on Wednesday

Fusion Pharmaceuticals (FUSN) surges to a new record level 52-week high after analysts at Raymond James upgraded its rating following the buyout announcements for two comparable companies.

Yahoo | December 28, 2023

New weight loss drugs are out of reach for millions of older Americans because Medicare won't pay

New obesity drugs are showing promising results in helping some people shed pounds but the injections will remain out of reach for millions of older Americans because Medicare is forbidden to cover such medications. As obesity rates rise among older adults, some lawmakers say the United States cannot afford to keep a decades-old law that prohibits Medicare from paying for new weight loss drugs, including Wegovy and Zepbound. A look at the debate around if — and how — Medicare should cover obesity drugs: WHAT OBESITY DRUGS ARE ON THE MARKET AND HOW DO THEY WORK?

Yahoo | December 28, 2023

Read More 'LLY' Stories Here

LLY Price Returns

1-mo -1.56%
3-mo 20.65%
6-mo 28.88%
1-year 104.66%
3-year 311.26%
5-year 603.84%
YTD 29.02%
2023 60.91%
2022 34.26%
2021 66.08%
2020 31.04%
2019 16.14%

LLY Dividends

Ex-Dividend Date Type Payout Amount Change
Loading, please wait...
View Full LLY Dividend History

Continue Researching LLY

Want to see what other sources are saying about ELI LILLY & Co's financials and stock price? Try the links below:

ELI LILLY & Co (LLY) Stock Price | Nasdaq
ELI LILLY & Co (LLY) Stock Quote, History and News - Yahoo Finance
ELI LILLY & Co (LLY) Stock Price and Basic Information | MarketWatch

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!